Psychoactive agents in dogs with bilateral lesions in subcortical structures.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D002421:Caudate Nucleus / Q000032:analysis / Q000187:drug effects / Q000503:physiopathology*; D002746:Chlorpromazine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D006624:Hippocampus / Q000032:analysis / Q000187:drug effects; D007031:Hypothalamus / Q000032:analysis; D009069:Movement Disorders / Q000188:drug therapy* / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology*; D014202:Tremor / Q000139:chemically induced
D012701:Serotonin; D012110:Reserpine; D006916:5-Hydroxytryptophan; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine